312 related articles for article (PubMed ID: 12150994)
1. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression.
Chen CR; Kang Y; Siegel PM; Massagué J
Cell; 2002 Jul; 110(1):19-32. PubMed ID: 12150994
[TBL] [Abstract][Full Text] [Related]
2. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
3. Smad about E2F. TGFbeta repressionof c-Myc via a Smad3/E2F/p107 complex.
Kowalik TF
Mol Cell; 2002 Jul; 10(1):7-8. PubMed ID: 12150900
[TBL] [Abstract][Full Text] [Related]
4. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.
Frederick JP; Liberati NT; Waddell DS; Shi Y; Wang XF
Mol Cell Biol; 2004 Mar; 24(6):2546-59. PubMed ID: 14993291
[TBL] [Abstract][Full Text] [Related]
6. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
7. Dynamic transcriptional regulatory complexes, including E2F4, p107, p130, and Sp1, control fibroblast growth factor receptor 1 gene expression during myogenesis.
Parakati R; DiMario JX
J Biol Chem; 2005 Jun; 280(22):21284-94. PubMed ID: 15811856
[TBL] [Abstract][Full Text] [Related]
8. c-myc is a downstream target of the Smad pathway.
Yagi K; Furuhashi M; Aoki H; Goto D; Kuwano H; Sugamura K; Miyazono K; Kato M
J Biol Chem; 2002 Jan; 277(1):854-61. PubMed ID: 11689553
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
10. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B).
Feng XH; Liang YY; Liang M; Zhai W; Lin X
Mol Cell; 2002 Jan; 9(1):133-43. PubMed ID: 11804592
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
12. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
13. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
15. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
17. E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins.
Dagnino L; Zhu L; Skorecki KL; Moses HL
Cell Growth Differ; 1995 Feb; 6(2):191-8. PubMed ID: 7756178
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
19. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
20. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.
Pilkinton M; Sandoval R; Colamonici OR
Oncogene; 2007 Nov; 26(54):7535-43. PubMed ID: 17563750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
